Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0695 USD | -6.03% | -16.27% | -36.82% |
2022 | CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor | CI |
2022 | CB Scientific, Inc. Appoints James Ott as Chief Technology Officer | CI |
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Ambulatory Non-invasive Cardiac Monitoring Space
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +9.04% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +9.04% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Charles Martin
CEO | Chief Executive Officer | - | 01/19/01 |
Director of Finance/CFO | - | 01/21/01 | |
James Ott
CTO | Chief Tech/Sci/R&D Officer | - | - |
Robert Kelley
BRD | Director/Board Member | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Danner
CHM | Chairman | 64 | 01/21/01 |
Charles Martin
CEO | Chief Executive Officer | - | 01/19/01 |
Robert Kelley
BRD | Director/Board Member | - | - |
James Ott
CTO | Chief Tech/Sci/R&D Officer | - | - |
Zbigniew Lambo
BRD | Director/Board Member | - | - |
Company contact information
CB Scientific, Inc.
10845 Griffith Peak Drive Suite 200
89135, Las Vegas
+888-225-0870
http://www.cbscientificinc.comSector
- Stock Market
- Equities
- CBSC Stock
- Company CB Scientific, Inc.